Article Cited by others REVIEW ARTICLE
Favipiravir and its potentials in COVID-19 pandemic: An update
Tam Dao Ngoc Hien, Qarawi Ahmad T, Luu Mai Ngoc, Turnage Morgan, Tran Linh, Tawfik Gehad Mohamed, Minh Le Huu Nhat, Huy Nguyen Tien, Iiyama Tatsuo, Kita Kyoshi, Hirayama Kenji
Year : 2021| Volume: 14| Issue : 10 | Page no: 433-439 This article has been cited by | 1 |
Identification of Z-Tyr-Ala-CHN2, a Cathepsin L Inhibitor with Broad-Spectrum Cell-Specific Activity against Coronaviruses, including SARS-CoV-2 |
|
| | Jordi Doijen, Koen Temmerman, Christel Van den Eynde, Annick Diels, Nick Van den Broeck, Michiel Van Gool, Inha Heo, Steffen Jaensch, Marleen Zwaagstra, Mayra Diosa Toro, Winston Chiu, Steven De Jonghe, Pieter Leyssen, Denisa Bojkova, Sandra Ciesek, Jindrich Cinatl, Lore Verschueren, Christophe Buyck, Frank Van Kuppeveld, Johan Neyts, Marnix Van Loock, Ellen Van Damme | | | Microorganisms. 2023; 11(3): 717 | | | [Pubmed] [Google Scholar] [DOI] | | 2 |
Effects of Vitamin C on the Oral-Nasal Mucosal Damage Caused by Favipiravir in Old and Young Rats |
|
| | Yücel Kurt, Özlem Özmen | | | Cureus. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | 3 |
Evaluation of the Effects of Favipiravir Combined with Vitamin C on Alveolar Bone in Rats |
|
| | A. Lektemur Alpan, G. Torumtay Cin, Ö. Özmen, M. F. Dogan, Y. Sahin | | | Journal of Evolutionary Biochemistry and Physiology. 2022; 58(2): 430 | | | [Pubmed] [Google Scholar] [DOI] | | 4 |
STUDY OF CLINICAL AND PATHOGENETIC EFFECTS OF ANTI-VIRAL DRUG BASED ON FAVIPIRAVIR IN COMORBID PATIENTS WITH COVID-19 AT THE OUTPATIENT STAGE OF TREATMENT |
|
| | L. A. Balykova, O. A. Radaeva, K. Ya. Zaslavskaya, Yu. A. Kostina, M. S. Iskandyarova, E. V. Negodnova, V. V. Eremeev, L. F. Sabirov, E. V. Semeleva | | | Pharmacy & Pharmacology. 2021; 9(6): 454 | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
|
|